Swiss PE investor Decalia Capital and founding minority shareholders have sold MediGroup to ImaOne, a leading doctor-led medical imaging platform active across France and Switzerland, combining radiology and nuclear medicine.
MediGroup, and outpatient radiology platform in Swiss Romandie operating a network of five medical imaging centres, was founded in 2015. It has developed from a single-centre provider into one of the leading pure-play radiology platforms in the region, offering diagnostic imaging and image-guided intervention services across MRI, CT-scan, X-Ray, ultrasound and mammography.
ImaOne, founded in Lyon by Reza Etessami and supported by Eurazeo and BPI France since 2022, operates a network of more than 25 centres and is pursuing a targeted growth strategy to build a leading European diagnostic imaging platform. The acquisition represents a strategic step for ImaOne, expanding its Swiss presence beyond its existing Geneva footprint into French-speaking Switzerland.
Decalia acquired a significant share in the company in 2020.
BYCap Advisory (Bertrand SIMON, Romain Munier, Elsa Saucourt) was M&A advisor to the shareholders of ImaOne. Acquirer legal advice and legal due diligence came from Archers Avocats (Marc Baffreau, Thomas Juillard, Pierre-Emmanuel Simon), and Vischer (Damien Conus, Yanick Corminboeuf). EY-Parthenon (Marc-Andre Audisio, Baptiste SÉSÉ) provided financial due diligence
M&A advisor to sellers was Lincoln International (Andy Roth, Norman La). Legal advisor was Jacquemoud Stanislas. Financial due diligence came from Avencia Capital (Mathieu Gravier)